Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 435 entries
Sorted by: Best Match Show Resources per page
Affective Correlates of Psychosis in Parkinson's Disease.

Movement disorders clinical practice

Factor SA, Scullin MK, Freeman A, Bliwise DL, McDonald WM, Goldstein FC.
PMID: 28944257
Mov Disord Clin Pract. 2017 Mar-Apr;4(2):225-230. doi: 10.1002/mdc3.12381. Epub 2016 Jun 16.

OBJECTIVE: To examine the nature of the association between affective disorders and psychosis in Parkinson's disease (PD).BACKGROUND: In PD, psychosis and affective disorders are common and independently impact quality of life and mortality. Both depression and psychosis are correlated...

Cite
Factor SA, Scullin MK, Freeman A, et al. Affective Correlates of Psychosis in Parkinson's Disease. Mov Disord Clin Pract. 2016;4(2):225-230doi: 10.1002/mdc3.12381.
Factor, S. A., Scullin, M. K., Freeman, A., Bliwise, D. L., McDonald, W. M., & Goldstein, F. C. (2017). Affective Correlates of Psychosis in Parkinson's Disease. Movement disorders clinical practice, 4(2), 225-230. https://doi.org/10.1002/mdc3.12381
Factor, Stewart A, et al. "Affective Correlates of Psychosis in Parkinson's Disease." Movement disorders clinical practice vol. 4,2 (2017): 225-230. doi: https://doi.org/10.1002/mdc3.12381
Factor SA, Scullin MK, Freeman A, Bliwise DL, McDonald WM, Goldstein FC. Affective Correlates of Psychosis in Parkinson's Disease. Mov Disord Clin Pract. 2017 Mar-Apr;4(2):225-230. doi: 10.1002/mdc3.12381. Epub 2016 Jun 16. PMID: 28944257; PMCID: PMC5608273.
Copy Download .nbib Format: NLM
Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells.

Molecular therapy. Methods & clinical development

Wang X, Herzog RW, Byrne BJ, Kumar SRP, Zhou Q, Buchholz CJ, Biswas M.
PMID: 28480307
Mol Ther Methods Clin Dev. 2017 Mar 29;5:76-82. doi: 10.1016/j.omtm.2017.03.005. eCollection 2017 Jun 16.

Gene-modified B cells expressing immunoglobulin G (IgG) fusion proteins have been shown to induce tolerance in several autoimmune and other disease models. However, lack of a vector suitable for gene transfer to human B cells has been an obstacle...

Cite
Wang X, Herzog RW, Byrne BJ, et al. Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells. Mol Ther Methods Clin Dev. 2017;5:76-82doi: 10.1016/j.omtm.2017.03.005.
Wang, X., Herzog, R. W., Byrne, B. J., Kumar, S. R. P., Zhou, Q., Buchholz, C. J., & Biswas, M. (2017). Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells. Molecular therapy. Methods & clinical development, 576-82. https://doi.org/10.1016/j.omtm.2017.03.005
Wang, Xiaomei, et al. "Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells." Molecular therapy. Methods & clinical development vol. 5 (2017): 76-82. doi: https://doi.org/10.1016/j.omtm.2017.03.005
Wang X, Herzog RW, Byrne BJ, Kumar SRP, Zhou Q, Buchholz CJ, Biswas M. Immune Modulatory Cell Therapy for Hemophilia B Based on CD20-Targeted Lentiviral Gene Transfer to Primary B Cells. Mol Ther Methods Clin Dev. 2017 Mar 29;5:76-82. doi: 10.1016/j.omtm.2017.03.005. eCollection 2017 Jun 16. PMID: 28480307; PMCID: PMC5415320.
Copy Download .nbib Format: NLM
Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target.

Pharmacology research & perspectives

Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, Feng KI, Metzger JM, Strapps WR, Tadin-Strapps M, Seiffert D, Andre P.
PMID: 26977298
Pharmacol Res Perspect. 2016 Jan 15;4(1):e00207. doi: 10.1002/prp2.207. eCollection 2016 Feb.

The benefits of novel oral anticoagulants are hampered by bleeding. Since coagulation factor IX (fIX) lies upstream of fX in the coagulation cascade, and intermediate levels have been associated with reduced incidence of thrombotic events, we evaluated the viability...

Cite
Ankrom W, Wood HB, Xu J, et al. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016;4(1):e00207doi: 10.1002/prp2.207.
Ankrom, W., Wood, H. B., Xu, J., Geissler, W., Bateman, T., Chatterjee, M. S., Feng, K. I., Metzger, J. M., Strapps, W. R., Tadin-Strapps, M., Seiffert, D., & Andre, P. (2016). Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacology research & perspectives, 4(1), e00207. https://doi.org/10.1002/prp2.207
Ankrom, Wendy, et al. "Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target." Pharmacology research & perspectives vol. 4,1 (2016): e00207. doi: https://doi.org/10.1002/prp2.207
Ankrom W, Wood HB, Xu J, Geissler W, Bateman T, Chatterjee MS, Feng KI, Metzger JM, Strapps WR, Tadin-Strapps M, Seiffert D, Andre P. Preclinical and translational evaluation of coagulation factor IXa as a novel therapeutic target. Pharmacol Res Perspect. 2016 Jan 15;4(1):e00207. doi: 10.1002/prp2.207. eCollection 2016 Feb. PMID: 26977298; PMCID: PMC4777260.
Copy Download .nbib Format: NLM
Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever.

The Eurasian journal of medicine

Ozkurt Z, Ozden K, Kiki I, Usanmaz M.
PMID: 25610169
Eurasian J Med. 2011 Aug;43(2):83-6. doi: 10.5152/eajm.2011.19.

OBJECTIVE: Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne viral hemorrhagic fever. Disseminated intravascular coagulation (DIC) is an important complication of this disease, especially in severe and fatal cases. Antithrombin (AT) acts as an anticoagulant by inactivating thrombin, Factor IX,...

Cite
Ozkurt Z, Ozden K, Kiki I, et al. Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever. Eurasian J Med. 2011;43(2):83-6doi: 10.5152/eajm.2011.19.
Ozkurt, Z., Ozden, K., Kiki, I., & Usanmaz, M. (2011). Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever. The Eurasian journal of medicine, 43(2), 83-6. https://doi.org/10.5152/eajm.2011.19
Ozkurt, Zulal, et al. "Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever." The Eurasian journal of medicine vol. 43,2 (2011): 83-6. doi: https://doi.org/10.5152/eajm.2011.19
Ozkurt Z, Ozden K, Kiki I, Usanmaz M. Prognostic significance of antithrombin activity in patients with crimean-congo hemorrhagic Fever. Eurasian J Med. 2011 Aug;43(2):83-6. doi: 10.5152/eajm.2011.19. PMID: 25610169; PMCID: PMC4261357.
Copy Download .nbib Format: NLM
Pharmacokinetic studies on a new purified factor IX concentrate.

Haemophilia : the official journal of the World Federation of Hemophilia

Thomas DP.
PMID: 27213707
Haemophilia. 1995;2:23-5. doi: 10.1111/j.1365-2516.1995.tb00098.x.

No abstract available.

Cite
Thomas DP. Pharmacokinetic studies on a new purified factor IX concentrate. Haemophilia. 1995;2:23-5doi: 10.1111/j.1365-2516.1995.tb00098.x.
Thomas, D. P. (1995). Pharmacokinetic studies on a new purified factor IX concentrate. Haemophilia : the official journal of the World Federation of Hemophilia, 223-5. https://doi.org/10.1111/j.1365-2516.1995.tb00098.x
Thomas, D P. "Pharmacokinetic studies on a new purified factor IX concentrate." Haemophilia : the official journal of the World Federation of Hemophilia vol. 2 (1995): 23-5. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00098.x
Thomas DP. Pharmacokinetic studies on a new purified factor IX concentrate. Haemophilia. 1995;2:23-5. doi: 10.1111/j.1365-2516.1995.tb00098.x. PMID: 27213707.
Copy Download .nbib Format: NLM
Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model.

Haemophilia : the official journal of the World Federation of Hemophilia

Nilsson IM, Berntorp E, Rickard KA.
PMID: 27214223
Haemophilia. 1995 Jan;1(1):59-66. doi: 10.1111/j.1365-2516.1995.tb00041.x.

Development of inhibitors to factor IX (F IX) is a serious complication of the treatment of patients with severe haemophilia B. Three Australian haemophilia B patients, a 22-year-old man and two 5-year-old identical twins, with high-responding inhibitors and resistant...

Cite
Nilsson IM, Berntorp E, Rickard KA. Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model. Haemophilia. 1995;1(1):59-66doi: 10.1111/j.1365-2516.1995.tb00041.x.
Nilsson, I. M., Berntorp, E., & Rickard, K. A. (1995). Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model. Haemophilia : the official journal of the World Federation of Hemophilia, 1(1), 59-66. https://doi.org/10.1111/j.1365-2516.1995.tb00041.x
Nilsson, I M, et al. "Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,1 (1995): 59-66. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00041.x
Nilsson IM, Berntorp E, Rickard KA. Results in three Australian haemophilia B patients with high-responding inhibitors treated with the Malmö model. Haemophilia. 1995 Jan;1(1):59-66. doi: 10.1111/j.1365-2516.1995.tb00041.x. PMID: 27214223.
Copy Download .nbib Format: NLM
Recombinant coagulation factor products.

Haemophilia : the official journal of the World Federation of Hemophilia

Brettler DB.
PMID: 27214531
Haemophilia. 1995 Jul;1(3):155-8. doi: 10.1111/j.1365-2516.1995.tb00059.x.

There are numerous new coagulation factor concentrates that are being manufactured using recombinant technology. Some are available for use currently for the treatment of bleeding disorders and others are in clinical trials. Recombinant factor VIII concentrates are licenced in...

Cite
Brettler DB. Recombinant coagulation factor products. Haemophilia. 1995;1(3):155-8doi: 10.1111/j.1365-2516.1995.tb00059.x.
Brettler, D. B. (1995). Recombinant coagulation factor products. Haemophilia : the official journal of the World Federation of Hemophilia, 1(3), 155-8. https://doi.org/10.1111/j.1365-2516.1995.tb00059.x
Brettler, D B. "Recombinant coagulation factor products." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,3 (1995): 155-8. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00059.x
Brettler DB. Recombinant coagulation factor products. Haemophilia. 1995 Jul;1(3):155-8. doi: 10.1111/j.1365-2516.1995.tb00059.x. PMID: 27214531.
Copy Download .nbib Format: NLM
The impact of prenatal diagnosis on the incidence of haemophilia in Sweden.

Haemophilia : the official journal of the World Federation of Hemophilia

Ljung R, Kling S, Tedgird U.
PMID: 27214538
Haemophilia. 1995 Jul;1(3):190-3. doi: 10.1111/j.1365-2516.1995.tb00066.x.

A demographic survey was made of all children (n= 137) born with severe or moderate haemophilia in Sweden during the period 1970-92. Bn addition, all prenatal diagnoses (n= 86) performing during the period were evaluated. The annual incidence of...

Cite
Ljung R, Kling S, Tedgird U. The impact of prenatal diagnosis on the incidence of haemophilia in Sweden. Haemophilia. 1995;1(3):190-3doi: 10.1111/j.1365-2516.1995.tb00066.x.
Ljung, R., Kling, S., & Tedgird, U. (1995). The impact of prenatal diagnosis on the incidence of haemophilia in Sweden. Haemophilia : the official journal of the World Federation of Hemophilia, 1(3), 190-3. https://doi.org/10.1111/j.1365-2516.1995.tb00066.x
Ljung, R, et al. "The impact of prenatal diagnosis on the incidence of haemophilia in Sweden." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,3 (1995): 190-3. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00066.x
Ljung R, Kling S, Tedgird U. The impact of prenatal diagnosis on the incidence of haemophilia in Sweden. Haemophilia. 1995 Jul;1(3):190-3. doi: 10.1111/j.1365-2516.1995.tb00066.x. PMID: 27214538.
Copy Download .nbib Format: NLM
A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates.

Haemophilia : the official journal of the World Federation of Hemophilia

Ming-Ching S, Fuei-Yuen L, Yen-Ping K, Ron-Fon H.
PMID: 27214631
Haemophilia. 1995 Oct;1(4):243-8. doi: 10.1111/j.1365-2516.1995.tb00083.x.

Twenty-four of 117 cases of haemophilia A (20.5%) and none of 18 cases of haemophilia B reported in this study had an antibody to the human immuno-deficiency virus (HIV). Both groups of patients showed similar immunological alterations. HIV-seropositive haemophilia...

Cite
Ming-Ching S, Fuei-Yuen L, Yen-Ping K, et al. A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates. Haemophilia. 1995;1(4):243-8doi: 10.1111/j.1365-2516.1995.tb00083.x.
Ming-Ching, S., Fuei-Yuen, L., Yen-Ping, K., & Ron-Fon, H. (1995). A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates. Haemophilia : the official journal of the World Federation of Hemophilia, 1(4), 243-8. https://doi.org/10.1111/j.1365-2516.1995.tb00083.x
Ming-Ching, S, et al. "A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates." Haemophilia : the official journal of the World Federation of Hemophilia vol. 1,4 (1995): 243-8. doi: https://doi.org/10.1111/j.1365-2516.1995.tb00083.x
Ming-Ching S, Fuei-Yuen L, Yen-Ping K, Ron-Fon H. A longitudinal study of immunological status in Chinese haemophiliacs: importance of the heat viral inactivation of factor concentrates. I. Immunological associations with the consumption of factor concentrates. Haemophilia. 1995 Oct;1(4):243-8. doi: 10.1111/j.1365-2516.1995.tb00083.x. PMID: 27214631.
Copy Download .nbib Format: NLM
Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines.

Turkish journal of haematology : official journal of Turkish Society of Haematology

Mutlu P, Ural AU, Gündüz U.
PMID: 25330516
Turk J Haematol. 2014 Sep 05;31(3):231-8. doi: 10.4274/tjh.2013.0231.

OBJECTIVE: Hemophilia B is caused by coagulation defects in the factor IX gene located in Xq27.1 on the X chromosome. A wide range of mutations, showing extensive molecular heterogeneity, have been described in hemophilia B patients. Our study was...

Cite
Mutlu P, Ural AU, Gündüz U. Hücre Döngüsü ve Apoptoz ile İlgili Gen İfadelerinin Kortikosteroid, Vinkristin ve Melfalan Dirençli U-266 Multipl Myelom Hücre Hatlarında Analizi. Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines. Turk J Haematol. 2014;31(3):231-8doi: 10.4274/tjh.2013.0231.
Mutlu, P., Ural, A. U., & Gündüz, U. (2014). Hücre Döngüsü ve Apoptoz ile İlgili Gen İfadelerinin Kortikosteroid, Vinkristin ve Melfalan Dirençli U-266 Multipl Myelom Hücre Hatlarında Analizi. Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines. Turkish journal of haematology : official journal of Turkish Society of Haematology, 31(3), 231-8. https://doi.org/10.4274/tjh.2013.0231
Mutlu, Pelin, et al. "Hücre Döngüsü ve Apoptoz ile İlgili Gen İfadelerinin Kortikosteroid, Vinkristin ve Melfalan Dirençli U-266 Multipl Myelom Hücre Hatlarında Analizi." Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines. Turkish journal of haematology : official journal of Turkish Society of Haematology vol. 31,3 (2014): 231-8. doi: https://doi.org/10.4274/tjh.2013.0231
Mutlu P, Ural AU, Gündüz U. Hücre Döngüsü ve Apoptoz ile İlgili Gen İfadelerinin Kortikosteroid, Vinkristin ve Melfalan Dirençli U-266 Multipl Myelom Hücre Hatlarında Analizi. Different types of cell cycle- and apoptosis-related gene expressions alter in corticosteroid-, vincristine-, and melphalan-resistant u-266 multiple myeloma cell lines. Turk J Haematol. 2014 Sep 05;31(3):231-8. doi: 10.4274/tjh.2013.0231. PMID: 25330516; PMCID: PMC4287023.
Copy Download .nbib Format: NLM
Erratum to: Functional expression of the human coagulation factor IX using heterologous signal peptide and propeptide sequences in mammalian cell line.

Biotechnology letters

Khorshidi S, Zomorodipour A, Behmanesh M, Vatandoost J, Bos MH.
PMID: 26253300
Biotechnol Lett. 2015 Oct;37(10):2097. doi: 10.1007/s10529-015-1909-y.

No abstract available.

Cite
Khorshidi S, Zomorodipour A, Behmanesh M, et al. Erratum to: Functional expression of the human coagulation factor IX using heterologous signal peptide and propeptide sequences in mammalian cell line. Biotechnol Lett. 2015;37(10):2097doi: 10.1007/s10529-015-1909-y.
Khorshidi, S., Zomorodipour, A., Behmanesh, M., Vatandoost, J., & Bos, M. H. (2015). Erratum to: Functional expression of the human coagulation factor IX using heterologous signal peptide and propeptide sequences in mammalian cell line. Biotechnology letters, 37(10), 2097. https://doi.org/10.1007/s10529-015-1909-y
Khorshidi, Shohreh, et al. "Erratum to: Functional expression of the human coagulation factor IX using heterologous signal peptide and propeptide sequences in mammalian cell line." Biotechnology letters vol. 37,10 (2015): 2097. doi: https://doi.org/10.1007/s10529-015-1909-y
Khorshidi S, Zomorodipour A, Behmanesh M, Vatandoost J, Bos MH. Erratum to: Functional expression of the human coagulation factor IX using heterologous signal peptide and propeptide sequences in mammalian cell line. Biotechnol Lett. 2015 Oct;37(10):2097. doi: 10.1007/s10529-015-1909-y. PMID: 26253300.
Copy Download .nbib Format: NLM
Cardiomyopathy in a male with cystinosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology

Edelman M, Silverstein D, Strom J, Factor SM.
PMID: 25943572
Cardiovasc Pathol. 1997 Jan;6(1):43-7. doi: 10.1016/S1054-8807(96)00047-6.

Cystinosis is a lysosomal storage disease classically associated with renal failure, photophobia, and hypothyroidism. Multi-organ dysfunction tends to develop over time, a factor of increasing significance as patient survival improves. Herein, we describe a male patient with cystinosis who...

Cite
Edelman M, Silverstein D, Strom J, et al. Cardiomyopathy in a male with cystinosis. Cardiovasc Pathol. 1997;6(1):43-7doi: 10.1016/S1054-8807(96)00047-6.
Edelman, M., Silverstein, D., Strom, J., & Factor, S. M. (1997). Cardiomyopathy in a male with cystinosis. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology, 6(1), 43-7. https://doi.org/10.1016/S1054-8807(96)00047-6
Edelman, M, et al. "Cardiomyopathy in a male with cystinosis." Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology vol. 6,1 (1997): 43-7. doi: https://doi.org/10.1016/S1054-8807(96)00047-6
Edelman M, Silverstein D, Strom J, Factor SM. Cardiomyopathy in a male with cystinosis. Cardiovasc Pathol. 1997 Jan;6(1):43-7. doi: 10.1016/S1054-8807(96)00047-6. PMID: 25943572.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 435 entries